Zika Virus Testing Market Report
The report on the Global Zika Virus Testing Market is segmented by Test Type (Nucleic Acid Amplification Testing (NAAT), Serological Testing), By End Use (Hospital/Clinic, Diagnostics Laboratory, Academic and Research Institutes), and Region. This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global zika virus testing market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The report on the Global Zika Virus Testing Market is segmented by Test Type (Nucleic Acid Amplification Testing (NAAT), Serological Testing), By End Use (Hospital/Clinic, Diagnostics Laboratory, Academic and Research Institutes), and Region. ...
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Global Zika Virus Testing Market is projected to grow from USD 155.6 million in 2020 to USD 240.2 million by 2026 at a CAGR of over 7.5% during the forecast period.
Figure: Global Zika Virus Testing Market Size, 2020-2026 (USD Million)
To know more about the report, click here and get a sample report.
Zika Virus is a mosquito borne disease that mainly affects the pregnant women and their fetus. Presently there is no vaccine developed against the virus, the treatment and testing prevails for cure of the affect. The infection of zika virus is endemic in Southeast Asia and Africa. The subsequent viral spread over the Pacific region has resulted in an outbreak in the developing and developed countries across the globe.
Key players operating in the global zika virus testing market are-
The growing prevalence of Zika Virus affected disease, rising emergency approval of POCT testing, growing government funding, and surging medical tourism are some of the key factors boosting the demand for zika virus testing.
By test type, the zika virus testing market has been segmented into Nucleic Acid Amplification Testing (NAAT) and serological testing.
By region, the North American market witnessed the largest market share in 2020 and is projected to grow at a healthy CAGR during the assessment period.
The ongoing COVID-19 pandemic has substantially affected the zika virus testing industry due to stringent lockdown measures and curbs on the movement of people. The unprecedented outbreak of coronavirus (SARS?CoV?2) has overshadowed another developing viral threat, which is the Zika flavivirus. The main concern currently to the governments across the globe is the escalating need to screen for and test large numbers of patients for possible COVID-19 infection. Thus, there has been a decline in the tests for the zika virus, thus affecting the industry growth.
?Wish to know more about the study? Click here.
The following is a list of the customers that the Zika Virus testing market aims to convert the most:
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].